Janda Kim 4
4 · Sorrento Therapeutics, Inc. · Filed Nov 27, 2018
Insider Transaction Report
Form 4
Janda Kim
Director
Transactions
- Award
Stock Options
[F1]2018-11-26+35,000→ 35,000 totalExercise: $3.57Exp: 2028-11-26→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]1/12 of the original number of shares subject to this option shall vest and become exercisable following each one month of service thereafter, subject to the Reporting Person's continued service on the Issuer's board of directors on each such date.
Signature
/s/ Henry Ji, Ph.D., as Attorney-in-Fact|2018-11-27